Ajanta Pharma Ltd
NSE :AJANTPHARM BSE :532331 Sector : PharmaceuticalsBuy, Sell or Hold AJANTPHARM? Ask The Analyst
BSE
prev close
OPEN PRICE
bid price (qty)
offer price (qty)
volume
Today's low / high
52 WK low / high
NSE
prev close
open price
bid price (qty)
offer price (qty)
volume
Today's' low / high
52 WK low / high
21 Nov 2945.50 (0.39%) | 19 Nov 2933.95 (1.56%) | 18 Nov 2888.95 (1.02%) | 14 Nov 2859.85 (1.24%) | 13 Nov 2824.90 (-0.46%) | 12 Nov 2838.05 (-0.67%) | 11 Nov 2857.30 (-0.24%) | 08 Nov 2864.20 (-4.07%) | 07 Nov 2985.60 (-4.18%) | 06 Nov 3115.90 (0.13%) | 05 Nov 3111.70 (4.26%) | 04 Nov 2984.50 (-3.29%) | 01 Nov 3086.15 (0.70%) | 31 Oct 3064.70 (2.27%) | 30 Oct 2996.65 (2.47%) | 29 Oct 2924.35 (0.06%) | 28 Oct 2922.60 (-1.57%) | 25 Oct 2969.30 (-0.06%) | 24 Oct 2970.95 (0.83%) | 23 Oct 2946.40 (-1.04%) | 22 Oct 2977.40 (-5.19%) |
Price Chart Historical Data Technical Chart
Technical Analysis
Short Term Investors
Bearish
Medium Term Investors
Very Bearish
Long Term Investors
Bullish
Moving Averages
5 DMA
Bullish
2895.83
10 DMA
Bullish
2914.53
20 DMA
Bearish
2956.72
50 DMA
Bearish
3137.24
100 DMA
Bullish
2927.18
200 DMA
Bullish
2582.39
Intraday Support and Resistance
(Based on Pivot Points) |
Updated On Nov 21, 2024 04:00 PM For Next Trading Session
Pivots | Classic | Fibonacci | Camarilla | Woodie | DM |
---|---|---|---|---|---|
R3 | 3036.95 | 3001.4 | 2962.96 | - | - |
R2 | 3001.4 | 2977.14 | 2957.14 | 3003.3 | - |
R1 | 2973.45 | 2962.16 | 2951.32 | 2977.25 | 2987.43 |
P | 2937.9 | 2937.9 | 2937.9 | 2939.8 | 2944.89 |
S1 | 2909.95 | 2913.64 | 2939.68 | 2913.75 | 2923.93 |
S2 | 2874.4 | 2898.66 | 2933.86 | 2876.3 | - |
S3 | 2846.45 | 2874.4 | 2928.04 | - | - |
Key Metrics
EPS
68.36
P/E
43.16
P/B
10.44
Dividend Yield
1.75%
Market Cap
36,793 Cr.
Face Value
2
Book Value
282.56
ROE
23.47%
EBITDA Growth
329.65 Cr.
Debt/Equity
0.01
Shareholding History
Quarterly Result (Figures in Rs. Crores)
Ajanta Pharma Ltd Quaterly Results
Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | |
INCOME | 1049.77 | 1118.74 | 1089.58 | 1171.39 | 1206.12 |
PROFIT | 195.3 | 210.03 | 202.72 | 245.77 | 216.48 |
EPS | 15.51 | 16.68 | 16.1 | 19.54 | 17.27 |
Ajanta Pharma Ltd Quaterly Results
Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | |
INCOME | 997.34 | 1099.02 | 959.75 | 1105.64 | 1169.25 |
PROFIT | 212.36 | 220.15 | 162.69 | 236.03 | 234.98 |
EPS | 16.87 | 17.48 | 12.92 | 18.77 | 18.75 |
Profit & Loss (Figures in Rs. Crores)
Ajanta Pharma Ltd Profit & Loss
Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | ||
INCOME | 1483.02 | 1819.79 | 2017.74 | 2199.14 | 2133.06 | 2696.81 | 3066.57 | 3539.84 | 3815.52 | 4332.52 | |
PROFIT | 314.81 | 416.7 | 509.77 | 468.65 | 387.14 | 470.53 | 651.29 | 713.28 | 594.01 | 808.03 | |
EPS | 22.94 | 31.33 | 38.2 | 35.32 | 29.41 | 35.55 | 50.13 | 55.34 | 46.54 | 64.6 |
Ajanta Pharma Ltd Profit & Loss
Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | ||
INCOME | 1380.68 | 1701.48 | 1863.99 | 1947.51 | 1942.15 | 2371.6 | 2896.76 | 3336.97 | 3566.01 | 4109.77 | |
PROFIT | 310.37 | 423.05 | 502.84 | 427.53 | 391.94 | 444.02 | 672.73 | 720.48 | 545.85 | 796.13 | |
EPS | 22.67 | 31.8 | 37.67 | 32.22 | 29.78 | 33.53 | 51.8 | 55.9 | 44.22 | 63.89 |
Balance Sheet (Figures in Rs. Crores)
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | |
SOURCES OF FUNDS : | ||||||||||
Share Capital | 25.27 | 25.27 | 17.17 | 17.39 | 17.54 | 17.54 | 17.69 | 17.69 | 17.69 | 17.68 |
Reserves Total | 3,542.09 | 3,362.72 | 3,247.17 | 2,978.24 | 2,581.33 | 2,227.67 | 2,023.68 | 1,550 | 1,173.17 | 823.41 |
Total Shareholders Funds | 3,567.36 | 3,387.99 | 3,264.34 | 2,995.63 | 2,598.87 | 2,245.21 | 2,041.37 | 1,567.69 | 1,190.86 | 841.09 |
Secured Loans | 1.49 | 1.43 | 1.91 | 1.69 | 45.68 | 35.96 | 1.8 | 1.28 | 59.63 | 61.61 |
Unsecured Loans | 33.79 | 34.2 | 23.12 | 29.67 | 29.28 | 0 | 0 | 0 | 21.72 | 10.77 |
Total Debt | 35.28 | 35.63 | 25.03 | 31.36 | 74.96 | 35.96 | 1.8 | 1.28 | 81.35 | 72.38 |
Other Liabilities | 43.25 | 27.83 | 23.41 | 22.52 | 19.78 | 13.77 | 13.16 | 4.97 | 3.05 | 7.26 |
Total Liabilities | 3,645.89 | 3,451.45 | 3,312.78 | 3,049.51 | 2,693.61 | 2,294.94 | 2,056.33 | 1,573.94 | 1,275.26 | 920.73 |
APPLICATION OF FUNDS : | ||||||||||
Gross Block | 2,389.41 | 2,282.82 | 2,217.79 | 2,140.78 | 1,976.15 | 1,593.35 | 1,417.23 | 879.01 | 715.73 | 549.85 |
Less: Accumulated Depreciation | 910.22 | 786.38 | 705.8 | 599.67 | 504.01 | 415.12 | 364.57 | 289.84 | 264.99 | 261.76 |
Net Block | 1,479.19 | 1,496.44 | 1,511.99 | 1,541.11 | 1,472.14 | 1,178.23 | 1,052.66 | 589.17 | 450.74 | 288.09 |
Capital Work in Progress | 256.45 | 209.47 | 152.86 | 108.19 | 131.86 | 261.61 | 61.33 | 339.26 | 239.8 | 170.2 |
Investments | 348.63 | 535.37 | 146.96 | 175.67 | 79.42 | 77.73 | 189.96 | 181.56 | 86.04 | 59.5 |
Inventories | 828.36 | 815.63 | 791.07 | 766.47 | 495.68 | 435.71 | 350.63 | 211.02 | 204.58 | 159.03 |
Sundry Debtors | 1,246.84 | 1,056.9 | 1,019.81 | 738.43 | 775.3 | 459.48 | 459.79 | 323.15 | 372.35 | 258.76 |
Cash and Bank Balance | 130.77 | 330.9 | 211.79 | 209.61 | 205.25 | 100.51 | 93.09 | 69.95 | 43.37 | 136.76 |
Loans and Advances | 194.9 | 120.3 | 119.93 | 137.41 | 98.34 | 119.37 | 137.73 | 64.92 | 66.19 | 59.4 |
Total Current Assets | 2,400.87 | 2,323.73 | 2,142.6 | 1,851.92 | 1,574.57 | 1,115.07 | 1,041.24 | 669.04 | 686.49 | 613.95 |
Current Liabilities | 821.47 | 1,082.76 | 622.18 | 576.41 | 523.06 | 334.67 | 312.79 | 224.27 | 182.06 | 146.16 |
Provisions | 62.53 | 47.09 | 18.75 | 60.63 | 20.86 | 7.67 | 32.47 | 22.15 | 11.35 | 64.3 |
Total Current Liabilities & Provisions | 884 | 1,129.85 | 640.93 | 637.04 | 543.92 | 342.34 | 345.26 | 246.42 | 193.41 | 210.46 |
Net Current Assets | 1,516.87 | 1,193.88 | 1,501.67 | 1,214.88 | 1,030.65 | 772.73 | 695.98 | 422.62 | 493.08 | 403.49 |
Deferred Tax Assets | 169.45 | 131.07 | 80.57 | 60.26 | 35.56 | 62.88 | 43.61 | 36.47 | 18.81 | 1.68 |
Deferred Tax Liability | 143.5 | 132.02 | 126.89 | 102.33 | 91.32 | 89.97 | 68 | 39.36 | 29.52 | 16.84 |
Net Deferred Tax | 25.95 | -0.95 | -46.32 | -42.07 | -55.76 | -27.09 | -24.39 | -2.89 | -10.71 | -15.16 |
Other Assets | 18.8 | 17.24 | 45.62 | 51.73 | 35.3 | 31.73 | 80.79 | 44.22 | 16.31 | 14.61 |
Total Assets | 3,645.89 | 3,451.45 | 3,312.78 | 3,049.51 | 2,693.61 | 2,294.94 | 2,056.33 | 1,573.94 | 1,275.26 | 920.73 |
Contingent Liabilities | 10.04 | 4.55 | 7.28 | 82.9 | 50.13 | 46.12 | 11.68 | 13.83 | 20.26 | 6.24 |
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | |
SOURCES OF FUNDS : | ||||||||||
Share Capital | 25.27 | 25.27 | 17.17 | 17.39 | 17.54 | 17.54 | 17.69 | 17.69 | 17.69 | 17.68 |
Reserves Total | 3,388.3 | 3,221.18 | 3,152.01 | 2,867.59 | 2,443.76 | 2,124.54 | 1,913.81 | 1,486.25 | 1,114.01 | 768.65 |
Total Shareholders Funds | 3,413.57 | 3,246.45 | 3,169.18 | 2,884.98 | 2,461.3 | 2,142.08 | 1,931.5 | 1,503.94 | 1,131.7 | 786.33 |
Secured Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 58.13 | 60.08 |
Unsecured Loans | 30.52 | 32.9 | 20.49 | 25.91 | 23.49 | 0 | 0 | 0 | 9.95 | 10.78 |
Total Debt | 30.52 | 32.9 | 20.49 | 25.91 | 23.49 | 0 | 0 | 0 | 68.08 | 70.86 |
Other Liabilities | 43.25 | 27.83 | 23.41 | 22.52 | 19.78 | 13.77 | 13.16 | 4.98 | 3.04 | 7.26 |
Total Liabilities | 3,487.34 | 3,307.18 | 3,213.08 | 2,933.41 | 2,504.57 | 2,155.85 | 1,944.66 | 1,508.92 | 1,202.82 | 864.45 |
APPLICATION OF FUNDS : | ||||||||||
Gross Block | 2,355.33 | 2,246.28 | 2,163.18 | 2,086.54 | 1,926.65 | 1,555.61 | 1,379.38 | 843.35 | 679.21 | 510.92 |
Less : Accumulated Depreciation | 890.44 | 762.27 | 670.86 | 567.75 | 477.33 | 393.59 | 342.69 | 270.42 | 246.38 | 239.6 |
Net Block | 1,464.89 | 1,484.01 | 1,492.32 | 1,518.79 | 1,449.32 | 1,162.02 | 1,036.69 | 572.93 | 432.83 | 271.32 |
Capital Work in Progress | 256.45 | 209.47 | 152.86 | 108.19 | 131.06 | 261.29 | 61.33 | 339.26 | 239.8 | 170.2 |
Investments | 367.14 | 553.26 | 164.85 | 156.88 | 85.77 | 83 | 200.64 | 198.82 | 94.03 | 76.62 |
Inventories | 677.79 | 683.77 | 635.11 | 634.22 | 436.19 | 414.26 | 317.37 | 179.28 | 189.78 | 153.05 |
Sundry Debtors | 1,207.67 | 977.63 | 1,043.62 | 782.3 | 734.24 | 423.38 | 432.19 | 336 | 350.48 | 240.85 |
Cash and Bank Balance | 63.06 | 269.92 | 145.25 | 151.98 | 87.85 | 35.87 | 38.67 | 22.84 | 21.44 | 105.69 |
Loans and Advances | 163.1 | 109.6 | 111.17 | 128.72 | 89.66 | 110.21 | 124.4 | 55.39 | 59.94 | 53.98 |
Total Current Assets | 2,111.62 | 2,040.92 | 1,935.15 | 1,697.22 | 1,347.94 | 983.72 | 912.63 | 593.51 | 621.64 | 553.57 |
Current Liabilities | 566.54 | 874.39 | 446.8 | 459.91 | 444.53 | 299.09 | 279.48 | 191.4 | 175.93 | 141.94 |
Provisions | 55.06 | 25.5 | 18.74 | 46.57 | 18.89 | 7.67 | 20.71 | 20.84 | 11.36 | 64.3 |
Total Current Liabilities & Provisions | 621.6 | 899.89 | 465.54 | 506.48 | 463.42 | 306.76 | 300.19 | 212.24 | 187.29 | 206.24 |
Net Current Assets | 1,490.02 | 1,141.03 | 1,469.61 | 1,190.74 | 884.52 | 676.96 | 612.44 | 381.27 | 434.35 | 347.33 |
Deferred Tax Assets | 35 | 34.3 | 28.15 | 0 | 0 | 0 | 21 | 11.98 | 5.82 | 1.68 |
Deferred Tax Liability | 143.5 | 132.02 | 130.02 | 92.17 | 81.16 | 58.9 | 68 | 39.36 | 29.4 | 16.84 |
Net Deferred Tax | -108.5 | -97.72 | -101.87 | -92.17 | -81.16 | -58.9 | -47 | -27.38 | -23.58 | -15.16 |
Other Assets | 17.34 | 17.13 | 35.31 | 50.98 | 35.06 | 31.48 | 80.56 | 44.02 | 25.39 | 14.14 |
Total Assets | 3,487.34 | 3,307.18 | 3,213.08 | 2,933.41 | 2,504.57 | 2,155.85 | 1,944.66 | 1,508.92 | 1,202.82 | 864.45 |
Contingent Liabilities | 10.04 | 4.55 | 7.28 | 82.9 | 50.13 | 46.12 | 11.77 | 13.91 | 20.35 | 6.46 |
Cash Flow (Figures in Rs. Crores)
Net Profit before Tax and Extr... | 1,113.93 |
Depreciation | 135.4 |
Interest (Net) | 7.21 |
P/L on Sales of Assets | -3.49 |
P/L in Forex | -9.42 |
Others | -389.19 |
Total Adjustments (PBT and Ext... | 83.03 |
Operating Profit before Workin... | 1,196.96 |
Trade and 0ther Receivables | -178.88 |
Inventories | -12.3 |
Trade Payables | 40.85 |
Loans and Advances | -16.57 |
Total Adjustments (OP before W... | -99.76 |
Cash Generated from/(used in) ... | 1,097.2 |
Direct Taxes Paid | -312.13 |
Total Adjustments(Cash Generat... | -312.13 |
Cash Flow before Extraordinary... | 785.07 |
Net Cash from Operating Activi... | 785.07 |
Sale of Fixed Assets | 13.38 |
Purchase of Investments | -2,079.76 |
Sale of Investments | 2,257.39 |
Net Cash used in Investing Act... | 65.39 |
Proceed from 0ther Long Term B... | 0.06 |
Of Financial Liabilities | -16.23 |
Dividend Paid | -642.17 |
Interest Paid | -3.53 |
Net Cash used in Financing Act... | -1,051.06 |
Net Profit before Tax and Extr... | 1,096.95 |
Depreciation | 132.16 |
Interest (Net) | 6.8 |
Dividend Received | 29.13 |
P/L on Sales of Assets | -3.49 |
P/L in Forex | -9.42 |
Others | -389.2 |
Total Adjustments (PBT and Ext... | 49.31 |
Operating Profit before Workin... | 1,146.26 |
Trade and 0ther Receivables | -221.02 |
Inventories | 5.98 |
Trade Payables | 30.86 |
Loans and Advances | 1.61 |
Total Adjustments (OP before W... | -158.63 |
Cash Generated from/(used in) ... | 987.63 |
Direct Taxes Paid | -252.28 |
Total Adjustments(Cash Generat... | -252.28 |
Cash Flow before Extraordinary... | 735.35 |
Net Cash from Operating Activi... | 735.35 |
Sale of Fixed Assets | 12.18 |
Purchase of Investments | -2,079.76 |
Sale of Investments | 2,257.39 |
Interest Received | 38.21 |
Net Cash used in Investing Act... | 105.02 |
Of Financial Liabilities | -12.91 |
Dividend Paid | -642.17 |
Interest Paid | -3.42 |
Net Cash used in Financing Act... | -1,047.7 |
Company Details
Registered Office |
|
Address | Ajanta House, Charkop Kandivli (W) |
City | Mumbai |
State | Maharashtra |
Pin Code | 400067 |
Tel. No. | 91-22-66061000/1204/1203 |
Fax. No. | 91-22-66061200/1300 |
info@ajantapharma.com; investorgrievance@ajantapha | |
Internet | http://www.ajantapharma.com |
Registrars |
|
Address | Ajanta House |
City | Mumbai |
State | Maharashtra |
Pin Code | 400067 |
Tel. No. | 91-22-66061000/1204/1203 |
Fax. No. | 91-22-66061200/1300 |
info@ajantapharma.com; investorgrievance@ajantapha | |
Internet | http://www.ajantapharma.com |
Management |
|
Name | Designation |
Mannalal B Agrawal | Chairman (Non-Executive) |
Madhusudan B Agrawal | Vice Chairman |
Yogesh Agrawal | Managing Director |
Chandrakanth M Khetan | Independent Director |
Gaurang Shah | Vice President & CS |
Rajesh M Agrawal | Joint Managing Director |
K H Viswanathan | Independent Director |
Prabhakar Dalal | Independent Director |
Anjana Grewal | Independent Director |
David Rasquinha | Independent Director |
Medha Joshi | Independent Director |
Simi Thapar | Independent Director |
Rajesh Shashikant Dalal | Independent Director |